Breaks Categories: News

WednesdayFeb 28, 2018 10:44 am

CBDNewsBreaks – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trial of CBD-based Formula Targeting Opioid Addiction

Earth Science Tech, Inc. (OTC: ETST) this morning reported that it has finalized preparations for its nine-month human trial to evaluate the effectiveness of a blend of broad-spectrum cannabinoid industrial hemp oil and essential mineral element. The trial seeks to develop a CBD formulation for the treatment of opioid addicts, relieving withdrawal symptoms, and averting fatal overdoses. ETST aims to increase the potency of its formulation by combining its full-spectrum cannabinoids industrial hemp oil with essential minerals. The trial is scheduled to be completed in 2019 and it will be supervised by ETST chief learning officer Gabriel Aviles and CEO…

Continue Reading

WednesdayFeb 28, 2018 10:14 am

CBDNewsBreaks – PotNetwork Holding Inc. (POTN) Featured in New Market Research Report

Cannabidiol-focused holding company PotNetwork Holding Inc. (OTC: POTN) was this morning announced as the subject of a comprehensive research report by independent equity research firm Traders News Source. The report notes that, in late December 2017, POTN shares were trading at $0.06, but the company’s PPS has hit record highs in the months since. In late January, POTN shares hit a high of $0.85, and POTN continue to trade near $0.48 per share. Traders News Source attributes this performance to a number of factors, including sustained revenue growth, POTN’s introduction of new product lines through its subsidiaries and the favorable…

Continue Reading

WednesdayFeb 28, 2018 10:11 am

CBDNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Releases Stock Dividend Details Regarding Spinoff of Hemp-related Assets

Market analysis company ChineseInvestors.com (OTCQB: CIIX) this morning released details of the stock dividends related to the company’s anticipated spinoff of its hemp-related assets including its China-based wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. and its wholly owned United States subsidiaries, ChineseHempOil.com, Inc. and Hemp Logic, Inc. In January, the subsidiaries attained combined sales of over $100,000.00 and are well positioned to continue to achieve significant growth in the future. The company intends to combine the three subsidiaries into a single private company and bring it to the public market in the 12 to 18 months that follow. The…

Continue Reading

WednesdayFeb 28, 2018 9:26 am

CBDNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Adds Senior Vice President of Marketing

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its appointment of Chris Gagan to the position of Senior Vice President of Marketing in a move that’s expected to play a key role in refining the company’s brand strategy. Gagan bring more than two decades of marketing and brand development experience to Choom, having previously led the design and development team for Canada’s largest national retailer of sporting goods, FGL Sports. As Choom’s Senior Vice President of Marketing, Gagan will provide leadership and guidance related to the execution of the company’s marketing efforts, as…

Continue Reading

WednesdayFeb 28, 2018 9:25 am

CBDNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Inks MOU with BioCan Technologies

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), a pharmaceutical and IP development firm, this morning announced that it has entered into a Memorandum of Understanding (“MOU”) with BioCan Technologies Inc. of Calgary, Alberta to collaborate exclusively to conduct additional investigations of cannabis strains being developed by Veritas’ research arm, Cannevert Therapeutics Ltd. (“CTL”). Optimizing the genetics of the cannabis plants for scientific and clinical testing over the next two years is the company’s primary focus during the collaboration. Definitive agreements relating to the MOU are anticipated to be signed by July 31, 2018. “BioCan’s geneticists will help CTL scientists…

Continue Reading

TuesdayFeb 27, 2018 3:33 pm

CBDNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO, Chief Research Officer Discuss Company’s Response to Opioid Epidemic

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was featured in an interview today by Proactive Investors. Chairman and CEO Stephen Van Deventer and chief research officer Dr. Harry Parekh discussed the company’s four programs: Sol-Gel, Nature Identical™, Dual Gene Therapy and Engineering Peptide Therapeutics. Among other topics, they discuss the rising rate of opioid overdoses and addiction, which the company’s planning to tackle utilizing its proprietary linker technology to engineer peptide therapeutics. “What's key about the technology is you cannot create tolerance to this treatment and you cannot overdose as well,” PreveCeutical chairman and CEO…

Continue Reading

TuesdayFeb 27, 2018 11:28 am

CBDNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Completes Acquisition of ERS Holdings; Announces Private Placement of Convertible Debentures

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) this morning announced the successful completion of its acquisition of ERS Holdings, LLC (“ERS”). ERS, a privately-held California company, has developed a patented technology called Ready-To-Infuse-Cannabis (“RTIC”) which covers the transformation of cannabis oil into powder for infusion into various food and beverage products. In addition, ERS has filed several continuation patents that would permit cannabis powder to be combined with other health and wellness products such as natural sleep-aids, cold medications and vitamins. Ross Franklin, co-inventor of the patent, has been appointed as the Director of Research and Development of ERS and…

Continue Reading

TuesdayFeb 27, 2018 10:52 am

CBDNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary CEO Comments on Crypto Cowboy, Sun Pacific Holding Corp. (SNPW) Agreement

Global Payout, Inc. (OTC: GOHE) this morning announced that Crypto Cowboy, LLC, of which the company’s wholly owned subsidiary MoneyTrac Technology, Inc. ("MTRAC") has a 5% stake, has entered into an agreement with Sun Pacific Holding Corp (OTC: SNPW) to collaborate together to build, develop, and manage a private exchange for coin-based tokens. The companies also intend to launch Crypto Cowboys' first private initial coin offering ("ICO") backed by Sun Pacific's Sun Green Coin. "This agreement between Crypto Cowboy and Sun Pacific is an incredible example of the impact and influence blockchain technology is just beginning to demonstrate across a…

Continue Reading

TuesdayFeb 27, 2018 10:22 am

CBDNewsBreaks – EVIO, Inc. (EVIO) Releases Letter to Shareholders

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning issued a letter to shareholders detailing its recent corporate milestones, fiscal results and projections, financing efforts and key management additions. “It is an exciting time to be involved in the cannabis industry, which is expected to double in size again by 2021 as more states look to legalize both medical and recreational cannabis use,” the letter reads. “Despite the risks inherent in any evolving marketplace, and despite the political uncertainty with respect to marijuana’s legal…

Continue Reading

TuesdayFeb 27, 2018 10:16 am

CBDNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Surpasses Million Dollar Mark, Achieves 300% YOY Sales Growth in February

PotNetwork Holding (OTC: POTN) this morning said that its wholly-owned subsidiary, Diamond CBD, Inc., exceeded $1 million dollars in sales during the first 15 days of February. Compared to the same period of last year, Diamond CBD’s sales have increased by 300%. In the past year, the subsidiary has brought to market over 15 recognizable CBD brands including products such as CBD oils, edible gummies and vape pens. Diamond CBD has recently unveiled its new product line targeting the nutritional supplements sector of the market with Meds BioTech. “Our objective throughout 2018 is consistent, solid and substantial growth. We are…

Continue Reading